human umbilical vein endothelial cells (huvecs Search Results


95
Cell Applications Inc huvec survival assay
Huvec Survival Assay, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+umbilical+vein+endothelial+cells+%28huvecs/pm40686280-422-0-13?v=Cell+Applications+Inc
Average 95 stars, based on 1 article reviews
huvec survival assay - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

95
ATCC human umbilical vein endothelial cells
Human Umbilical Vein Endothelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+umbilical+vein+endothelial+cells+%28huvecs/pmc12979711-92-0-6?v=ATCC
Average 95 stars, based on 1 article reviews
human umbilical vein endothelial cells - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

92
Angio-Proteomie huvecs
a Live-cell fluorescence images (one image per four chambers) showing an overview of all the chambers after 3 days of <t>culturing</t> <t>GFP-expressing</t> <t>HUVECs.</t> b Live-cell fluorescence image of GFP-expressing HUVECs in chambers 6 and 7. c Fluorescence image of fixed HUVECs with the cell F-actin and nuclei stained with ActinRed and NucBlue, respectively. d HUVECs after seeding and subsequent monolayer formation. The cells were seeded at a high cell density (i) and confluent on day 1 (ii). The monolayer was still intact on day 3 (iii) but began to deteriorate on day 4 (iv). At this point, the medium in the supply vial was replaced. The cells showed signs of recovery on day 5 (v) as the monolayer started to reform. The red dots in (iv) and (v) mark the cells counted in the region of interest. e Cells in ten chambers were counted in regions where the monolayer had deteriorated on day 4 (98 h) and after 16 h of recovery (114 h). The black dots represent the mean cell count, and the error bars represent the standard deviation. The cell number increased by an average of 33% in these areas
Huvecs, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+umbilical+vein+endothelial+cells+%28huvecs/pmc08433198-369-5-6?v=Angio-Proteomie
Average 92 stars, based on 1 article reviews
huvecs - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

99
Lonza human umbilical vein endothelial cells
a Live-cell fluorescence images (one image per four chambers) showing an overview of all the chambers after 3 days of <t>culturing</t> <t>GFP-expressing</t> <t>HUVECs.</t> b Live-cell fluorescence image of GFP-expressing HUVECs in chambers 6 and 7. c Fluorescence image of fixed HUVECs with the cell F-actin and nuclei stained with ActinRed and NucBlue, respectively. d HUVECs after seeding and subsequent monolayer formation. The cells were seeded at a high cell density (i) and confluent on day 1 (ii). The monolayer was still intact on day 3 (iii) but began to deteriorate on day 4 (iv). At this point, the medium in the supply vial was replaced. The cells showed signs of recovery on day 5 (v) as the monolayer started to reform. The red dots in (iv) and (v) mark the cells counted in the region of interest. e Cells in ten chambers were counted in regions where the monolayer had deteriorated on day 4 (98 h) and after 16 h of recovery (114 h). The black dots represent the mean cell count, and the error bars represent the standard deviation. The cell number increased by an average of 33% in these areas
Human Umbilical Vein Endothelial Cells, supplied by Lonza, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+umbilical+vein+endothelial+cells+%28huvecs/pmc04036321-213-0-10?v=Lonza
Average 99 stars, based on 1 article reviews
human umbilical vein endothelial cells - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

90
Cell Applications Inc human umbilical vein
a Live-cell fluorescence images (one image per four chambers) showing an overview of all the chambers after 3 days of <t>culturing</t> <t>GFP-expressing</t> <t>HUVECs.</t> b Live-cell fluorescence image of GFP-expressing HUVECs in chambers 6 and 7. c Fluorescence image of fixed HUVECs with the cell F-actin and nuclei stained with ActinRed and NucBlue, respectively. d HUVECs after seeding and subsequent monolayer formation. The cells were seeded at a high cell density (i) and confluent on day 1 (ii). The monolayer was still intact on day 3 (iii) but began to deteriorate on day 4 (iv). At this point, the medium in the supply vial was replaced. The cells showed signs of recovery on day 5 (v) as the monolayer started to reform. The red dots in (iv) and (v) mark the cells counted in the region of interest. e Cells in ten chambers were counted in regions where the monolayer had deteriorated on day 4 (98 h) and after 16 h of recovery (114 h). The black dots represent the mean cell count, and the error bars represent the standard deviation. The cell number increased by an average of 33% in these areas
Human Umbilical Vein, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+umbilical+vein+endothelial+cells+%28huvecs/pm18988897-24-0-16?v=Cell+Applications+Inc
Average 90 stars, based on 1 article reviews
human umbilical vein - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
PROVITRO GmbH primary human umbilical vein endothelial cells (huvecs)
a Live-cell fluorescence images (one image per four chambers) showing an overview of all the chambers after 3 days of <t>culturing</t> <t>GFP-expressing</t> <t>HUVECs.</t> b Live-cell fluorescence image of GFP-expressing HUVECs in chambers 6 and 7. c Fluorescence image of fixed HUVECs with the cell F-actin and nuclei stained with ActinRed and NucBlue, respectively. d HUVECs after seeding and subsequent monolayer formation. The cells were seeded at a high cell density (i) and confluent on day 1 (ii). The monolayer was still intact on day 3 (iii) but began to deteriorate on day 4 (iv). At this point, the medium in the supply vial was replaced. The cells showed signs of recovery on day 5 (v) as the monolayer started to reform. The red dots in (iv) and (v) mark the cells counted in the region of interest. e Cells in ten chambers were counted in regions where the monolayer had deteriorated on day 4 (98 h) and after 16 h of recovery (114 h). The black dots represent the mean cell count, and the error bars represent the standard deviation. The cell number increased by an average of 33% in these areas
Primary Human Umbilical Vein Endothelial Cells (Huvecs), supplied by PROVITRO GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+umbilical+vein+endothelial+cells+%28huvecs/pmc04877919-146-2-12?v=PROVITRO+GmbH
Average 90 stars, based on 1 article reviews
primary human umbilical vein endothelial cells (huvecs) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
ScienCell human umbilical vein endothelial cells (huvec)
a Live-cell fluorescence images (one image per four chambers) showing an overview of all the chambers after 3 days of <t>culturing</t> <t>GFP-expressing</t> <t>HUVECs.</t> b Live-cell fluorescence image of GFP-expressing HUVECs in chambers 6 and 7. c Fluorescence image of fixed HUVECs with the cell F-actin and nuclei stained with ActinRed and NucBlue, respectively. d HUVECs after seeding and subsequent monolayer formation. The cells were seeded at a high cell density (i) and confluent on day 1 (ii). The monolayer was still intact on day 3 (iii) but began to deteriorate on day 4 (iv). At this point, the medium in the supply vial was replaced. The cells showed signs of recovery on day 5 (v) as the monolayer started to reform. The red dots in (iv) and (v) mark the cells counted in the region of interest. e Cells in ten chambers were counted in regions where the monolayer had deteriorated on day 4 (98 h) and after 16 h of recovery (114 h). The black dots represent the mean cell count, and the error bars represent the standard deviation. The cell number increased by an average of 33% in these areas
Human Umbilical Vein Endothelial Cells (Huvec), supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+umbilical+vein+endothelial+cells+%28huvecs/pmc05473878-46-2-13?v=ScienCell
Average 90 stars, based on 1 article reviews
human umbilical vein endothelial cells (huvec) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
TCS Cellworks human umbilical vein ecs
a Live-cell fluorescence images (one image per four chambers) showing an overview of all the chambers after 3 days of <t>culturing</t> <t>GFP-expressing</t> <t>HUVECs.</t> b Live-cell fluorescence image of GFP-expressing HUVECs in chambers 6 and 7. c Fluorescence image of fixed HUVECs with the cell F-actin and nuclei stained with ActinRed and NucBlue, respectively. d HUVECs after seeding and subsequent monolayer formation. The cells were seeded at a high cell density (i) and confluent on day 1 (ii). The monolayer was still intact on day 3 (iii) but began to deteriorate on day 4 (iv). At this point, the medium in the supply vial was replaced. The cells showed signs of recovery on day 5 (v) as the monolayer started to reform. The red dots in (iv) and (v) mark the cells counted in the region of interest. e Cells in ten chambers were counted in regions where the monolayer had deteriorated on day 4 (98 h) and after 16 h of recovery (114 h). The black dots represent the mean cell count, and the error bars represent the standard deviation. The cell number increased by an average of 33% in these areas
Human Umbilical Vein Ecs, supplied by TCS Cellworks, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+umbilical+vein+endothelial+cells+%28huvecs/pmc02271006-100-0-11?v=TCS+Cellworks
Average 90 stars, based on 1 article reviews
human umbilical vein ecs - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lonza human umbilical vein endothelial cells (huvec)
a Live-cell fluorescence images (one image per four chambers) showing an overview of all the chambers after 3 days of <t>culturing</t> <t>GFP-expressing</t> <t>HUVECs.</t> b Live-cell fluorescence image of GFP-expressing HUVECs in chambers 6 and 7. c Fluorescence image of fixed HUVECs with the cell F-actin and nuclei stained with ActinRed and NucBlue, respectively. d HUVECs after seeding and subsequent monolayer formation. The cells were seeded at a high cell density (i) and confluent on day 1 (ii). The monolayer was still intact on day 3 (iii) but began to deteriorate on day 4 (iv). At this point, the medium in the supply vial was replaced. The cells showed signs of recovery on day 5 (v) as the monolayer started to reform. The red dots in (iv) and (v) mark the cells counted in the region of interest. e Cells in ten chambers were counted in regions where the monolayer had deteriorated on day 4 (98 h) and after 16 h of recovery (114 h). The black dots represent the mean cell count, and the error bars represent the standard deviation. The cell number increased by an average of 33% in these areas
Human Umbilical Vein Endothelial Cells (Huvec), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+umbilical+vein+endothelial+cells+%28huvecs/pmc04029959-34-20-28?v=Lonza
Average 90 stars, based on 1 article reviews
human umbilical vein endothelial cells (huvec) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Kurabo industries human umbilical vein endothelial cells (huvecs
a Live-cell fluorescence images (one image per four chambers) showing an overview of all the chambers after 3 days of <t>culturing</t> <t>GFP-expressing</t> <t>HUVECs.</t> b Live-cell fluorescence image of GFP-expressing HUVECs in chambers 6 and 7. c Fluorescence image of fixed HUVECs with the cell F-actin and nuclei stained with ActinRed and NucBlue, respectively. d HUVECs after seeding and subsequent monolayer formation. The cells were seeded at a high cell density (i) and confluent on day 1 (ii). The monolayer was still intact on day 3 (iii) but began to deteriorate on day 4 (iv). At this point, the medium in the supply vial was replaced. The cells showed signs of recovery on day 5 (v) as the monolayer started to reform. The red dots in (iv) and (v) mark the cells counted in the region of interest. e Cells in ten chambers were counted in regions where the monolayer had deteriorated on day 4 (98 h) and after 16 h of recovery (114 h). The black dots represent the mean cell count, and the error bars represent the standard deviation. The cell number increased by an average of 33% in these areas
Human Umbilical Vein Endothelial Cells (Huvecs, supplied by Kurabo industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+umbilical+vein+endothelial+cells+%28huvecs/pmc00538793-48-0-15?v=Kurabo+industries
Average 90 stars, based on 1 article reviews
human umbilical vein endothelial cells (huvecs - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lonza human umbilical cord endothelial cells huvec passage 3
a Live-cell fluorescence images (one image per four chambers) showing an overview of all the chambers after 3 days of <t>culturing</t> <t>GFP-expressing</t> <t>HUVECs.</t> b Live-cell fluorescence image of GFP-expressing HUVECs in chambers 6 and 7. c Fluorescence image of fixed HUVECs with the cell F-actin and nuclei stained with ActinRed and NucBlue, respectively. d HUVECs after seeding and subsequent monolayer formation. The cells were seeded at a high cell density (i) and confluent on day 1 (ii). The monolayer was still intact on day 3 (iii) but began to deteriorate on day 4 (iv). At this point, the medium in the supply vial was replaced. The cells showed signs of recovery on day 5 (v) as the monolayer started to reform. The red dots in (iv) and (v) mark the cells counted in the region of interest. e Cells in ten chambers were counted in regions where the monolayer had deteriorated on day 4 (98 h) and after 16 h of recovery (114 h). The black dots represent the mean cell count, and the error bars represent the standard deviation. The cell number increased by an average of 33% in these areas
Human Umbilical Cord Endothelial Cells Huvec Passage 3, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+umbilical+vein+endothelial+cells+%28huvecs/pmc03893854-111-14-21?v=Lonza
Average 90 stars, based on 1 article reviews
human umbilical cord endothelial cells huvec passage 3 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
BioResource International Inc human umbilical vein endothelial cells (huvecs) bcrc h‑uv001
a Live-cell fluorescence images (one image per four chambers) showing an overview of all the chambers after 3 days of <t>culturing</t> <t>GFP-expressing</t> <t>HUVECs.</t> b Live-cell fluorescence image of GFP-expressing HUVECs in chambers 6 and 7. c Fluorescence image of fixed HUVECs with the cell F-actin and nuclei stained with ActinRed and NucBlue, respectively. d HUVECs after seeding and subsequent monolayer formation. The cells were seeded at a high cell density (i) and confluent on day 1 (ii). The monolayer was still intact on day 3 (iii) but began to deteriorate on day 4 (iv). At this point, the medium in the supply vial was replaced. The cells showed signs of recovery on day 5 (v) as the monolayer started to reform. The red dots in (iv) and (v) mark the cells counted in the region of interest. e Cells in ten chambers were counted in regions where the monolayer had deteriorated on day 4 (98 h) and after 16 h of recovery (114 h). The black dots represent the mean cell count, and the error bars represent the standard deviation. The cell number increased by an average of 33% in these areas
Human Umbilical Vein Endothelial Cells (Huvecs) Bcrc H‑Uv001, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+umbilical+vein+endothelial+cells+%28huvecs/pm26397389-44-0-8?v=BioResource+International+Inc
Average 90 stars, based on 1 article reviews
human umbilical vein endothelial cells (huvecs) bcrc h‑uv001 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


a Live-cell fluorescence images (one image per four chambers) showing an overview of all the chambers after 3 days of culturing GFP-expressing HUVECs. b Live-cell fluorescence image of GFP-expressing HUVECs in chambers 6 and 7. c Fluorescence image of fixed HUVECs with the cell F-actin and nuclei stained with ActinRed and NucBlue, respectively. d HUVECs after seeding and subsequent monolayer formation. The cells were seeded at a high cell density (i) and confluent on day 1 (ii). The monolayer was still intact on day 3 (iii) but began to deteriorate on day 4 (iv). At this point, the medium in the supply vial was replaced. The cells showed signs of recovery on day 5 (v) as the monolayer started to reform. The red dots in (iv) and (v) mark the cells counted in the region of interest. e Cells in ten chambers were counted in regions where the monolayer had deteriorated on day 4 (98 h) and after 16 h of recovery (114 h). The black dots represent the mean cell count, and the error bars represent the standard deviation. The cell number increased by an average of 33% in these areas

Journal: Microsystems & Nanoengineering

Article Title: Modular operation of microfluidic chips for highly parallelized cell culture and liquid dosing via a fluidic circuit board

doi: 10.1038/s41378-020-00216-z

Figure Lengend Snippet: a Live-cell fluorescence images (one image per four chambers) showing an overview of all the chambers after 3 days of culturing GFP-expressing HUVECs. b Live-cell fluorescence image of GFP-expressing HUVECs in chambers 6 and 7. c Fluorescence image of fixed HUVECs with the cell F-actin and nuclei stained with ActinRed and NucBlue, respectively. d HUVECs after seeding and subsequent monolayer formation. The cells were seeded at a high cell density (i) and confluent on day 1 (ii). The monolayer was still intact on day 3 (iii) but began to deteriorate on day 4 (iv). At this point, the medium in the supply vial was replaced. The cells showed signs of recovery on day 5 (v) as the monolayer started to reform. The red dots in (iv) and (v) mark the cells counted in the region of interest. e Cells in ten chambers were counted in regions where the monolayer had deteriorated on day 4 (98 h) and after 16 h of recovery (114 h). The black dots represent the mean cell count, and the error bars represent the standard deviation. The cell number increased by an average of 33% in these areas

Article Snippet: Live-cell images of the GFP-expressing HUVECs (Angio-Proteomie, USA) were taken with an EVOS FL cell imaging system using the GFP filter cube.

Techniques: Fluorescence, Expressing, Staining, Cell Counting, Standard Deviation